 | • レポートコード：QYR2104Z6190 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、ナノ化学療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（医学療法、理学療法、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・ナノ化学療法の市場動向 ・企業の競争状況、市場シェア ・ナノ化学療法の種類別市場規模（医学療法、理学療法、その他） ・ナノ化学療法の用途別市場規模（病院、診療所、その他） ・ナノ化学療法の北米市場規模2016-2027（アメリカ、カナダ） ・ナノ化学療法のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・ナノ化学療法のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ナノ化学療法の中南米市場規模2016-2027（メキシコ、ブラジル） ・ナノ化学療法の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Amgen、Celgene、MagForce AG、Nanotherapeutics、Spectrum Pharmaceuticals、Ablynx、AMAG、CytImmune、Delpor、Nanospectra、Merrimack、Tarveda） ・結論 |
Market Analysis and Insights: Global Nano Chemotherapy Market
The global Nano Chemotherapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Nano Chemotherapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Nano Chemotherapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Nano Chemotherapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Nano Chemotherapy market.
Global Nano Chemotherapy Scope and Market Size
Nano Chemotherapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Nano Chemotherapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Medicine Therapy
Physical Therapy
Other
Segment by Application
Hospitals
Clinics
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Amgen
Celgene
MagForce AG
Nanotherapeutics
Spectrum Pharmaceuticals
Ablynx
AMAG
CytImmune
Delpor
Nanotherapeutics
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nano Chemotherapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Medicine Therapy
1.2.3 Physical Therapy
1.2.4 Other
1.3 Market by Application
1.3.1 Global Nano Chemotherapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Nano Chemotherapy Market Perspective (2016-2027)
2.2 Nano Chemotherapy Growth Trends by Regions
2.2.1 Nano Chemotherapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Nano Chemotherapy Historic Market Share by Regions (2016-2021)
2.2.3 Nano Chemotherapy Forecasted Market Size by Regions (2022-2027)
2.3 Nano Chemotherapy Industry Dynamic
2.3.1 Nano Chemotherapy Market Trends
2.3.2 Nano Chemotherapy Market Drivers
2.3.3 Nano Chemotherapy Market Challenges
2.3.4 Nano Chemotherapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nano Chemotherapy Players by Revenue
3.1.1 Global Top Nano Chemotherapy Players by Revenue (2016-2021)
3.1.2 Global Nano Chemotherapy Revenue Market Share by Players (2016-2021)
3.2 Global Nano Chemotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Nano Chemotherapy Revenue
3.4 Global Nano Chemotherapy Market Concentration Ratio
3.4.1 Global Nano Chemotherapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nano Chemotherapy Revenue in 2020
3.5 Nano Chemotherapy Key Players Head office and Area Served
3.6 Key Players Nano Chemotherapy Product Solution and Service
3.7 Date of Enter into Nano Chemotherapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nano Chemotherapy Breakdown Data by Type
4.1 Global Nano Chemotherapy Historic Market Size by Type (2016-2021)
4.2 Global Nano Chemotherapy Forecasted Market Size by Type (2022-2027)
5 Nano Chemotherapy Breakdown Data by Application
5.1 Global Nano Chemotherapy Historic Market Size by Application (2016-2021)
5.2 Global Nano Chemotherapy Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Nano Chemotherapy Market Size (2016-2027)
6.2 North America Nano Chemotherapy Market Size by Type
6.2.1 North America Nano Chemotherapy Market Size by Type (2016-2021)
6.2.2 North America Nano Chemotherapy Market Size by Type (2022-2027)
6.2.3 North America Nano Chemotherapy Market Size by Type (2016-2027)
6.3 North America Nano Chemotherapy Market Size by Application
6.3.1 North America Nano Chemotherapy Market Size by Application (2016-2021)
6.3.2 North America Nano Chemotherapy Market Size by Application (2022-2027)
6.3.3 North America Nano Chemotherapy Market Size by Application (2016-2027)
6.4 North America Nano Chemotherapy Market Size by Country
6.4.1 North America Nano Chemotherapy Market Size by Country (2016-2021)
6.4.2 North America Nano Chemotherapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Nano Chemotherapy Market Size (2016-2027)
7.2 Europe Nano Chemotherapy Market Size by Type
7.2.1 Europe Nano Chemotherapy Market Size by Type (2016-2021)
7.2.2 Europe Nano Chemotherapy Market Size by Type (2022-2027)
7.2.3 Europe Nano Chemotherapy Market Size by Type (2016-2027)
7.3 Europe Nano Chemotherapy Market Size by Application
7.3.1 Europe Nano Chemotherapy Market Size by Application (2016-2021)
7.3.2 Europe Nano Chemotherapy Market Size by Application (2022-2027)
7.3.3 Europe Nano Chemotherapy Market Size by Application (2016-2027)
7.4 Europe Nano Chemotherapy Market Size by Country
7.4.1 Europe Nano Chemotherapy Market Size by Country (2016-2021)
7.4.2 Europe Nano Chemotherapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Nano Chemotherapy Market Size (2016-2027)
8.2 Asia-Pacific Nano Chemotherapy Market Size by Type
8.2.1 Asia-Pacific Nano Chemotherapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Nano Chemotherapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Nano Chemotherapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Nano Chemotherapy Market Size by Application
8.3.1 Asia-Pacific Nano Chemotherapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Nano Chemotherapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Nano Chemotherapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Nano Chemotherapy Market Size by Region
8.4.1 Asia-Pacific Nano Chemotherapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Nano Chemotherapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Nano Chemotherapy Market Size (2016-2027)
9.2 Latin America Nano Chemotherapy Market Size by Type
9.2.1 Latin America Nano Chemotherapy Market Size by Type (2016-2021)
9.2.2 Latin America Nano Chemotherapy Market Size by Type (2022-2027)
9.2.3 Latin America Nano Chemotherapy Market Size by Type (2016-2027)
9.3 Latin America Nano Chemotherapy Market Size by Application
9.3.1 Latin America Nano Chemotherapy Market Size by Application (2016-2021)
9.3.2 Latin America Nano Chemotherapy Market Size by Application (2022-2027)
9.3.3 Latin America Nano Chemotherapy Market Size by Application (2016-2027)
9.4 Latin America Nano Chemotherapy Market Size by Country
9.4.1 Latin America Nano Chemotherapy Market Size by Country (2016-2021)
9.4.2 Latin America Nano Chemotherapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nano Chemotherapy Market Size (2016-2027)
10.2 Middle East & Africa Nano Chemotherapy Market Size by Type
10.2.1 Middle East & Africa Nano Chemotherapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Nano Chemotherapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Nano Chemotherapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Nano Chemotherapy Market Size by Application
10.3.1 Middle East & Africa Nano Chemotherapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Nano Chemotherapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Nano Chemotherapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Nano Chemotherapy Market Size by Country
10.4.1 Middle East & Africa Nano Chemotherapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Nano Chemotherapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Amgen Business Overview
11.1.3 Amgen Nano Chemotherapy Introduction
11.1.4 Amgen Revenue in Nano Chemotherapy Business (2016-2021)
11.1.5 Amgen Recent Development
11.2 Celgene
11.2.1 Celgene Company Details
11.2.2 Celgene Business Overview
11.2.3 Celgene Nano Chemotherapy Introduction
11.2.4 Celgene Revenue in Nano Chemotherapy Business (2016-2021)
11.2.5 Celgene Recent Development
11.3 MagForce AG
11.3.1 MagForce AG Company Details
11.3.2 MagForce AG Business Overview
11.3.3 MagForce AG Nano Chemotherapy Introduction
11.3.4 MagForce AG Revenue in Nano Chemotherapy Business (2016-2021)
11.3.5 MagForce AG Recent Development
11.4 Nanotherapeutics
11.4.1 Nanotherapeutics Company Details
11.4.2 Nanotherapeutics Business Overview
11.4.3 Nanotherapeutics Nano Chemotherapy Introduction
11.4.4 Nanotherapeutics Revenue in Nano Chemotherapy Business (2016-2021)
11.4.5 Nanotherapeutics Recent Development
11.5 Spectrum Pharmaceuticals
11.5.1 Spectrum Pharmaceuticals Company Details
11.5.2 Spectrum Pharmaceuticals Business Overview
11.5.3 Spectrum Pharmaceuticals Nano Chemotherapy Introduction
11.5.4 Spectrum Pharmaceuticals Revenue in Nano Chemotherapy Business (2016-2021)
11.5.5 Spectrum Pharmaceuticals Recent Development
11.6 Ablynx
11.6.1 Ablynx Company Details
11.6.2 Ablynx Business Overview
11.6.3 Ablynx Nano Chemotherapy Introduction
11.6.4 Ablynx Revenue in Nano Chemotherapy Business (2016-2021)
11.6.5 Ablynx Recent Development
11.7 AMAG
11.7.1 AMAG Company Details
11.7.2 AMAG Business Overview
11.7.3 AMAG Nano Chemotherapy Introduction
11.7.4 AMAG Revenue in Nano Chemotherapy Business (2016-2021)
11.7.5 AMAG Recent Development
11.8 CytImmune
11.8.1 CytImmune Company Details
11.8.2 CytImmune Business Overview
11.8.3 CytImmune Nano Chemotherapy Introduction
11.8.4 CytImmune Revenue in Nano Chemotherapy Business (2016-2021)
11.8.5 CytImmune Recent Development
11.9 Delpor
11.9.1 Delpor Company Details
11.9.2 Delpor Business Overview
11.9.3 Delpor Nano Chemotherapy Introduction
11.9.4 Delpor Revenue in Nano Chemotherapy Business (2016-2021)
11.9.5 Delpor Recent Development
11.10 Nanospectra
11.10.1 Nanospectra Company Details
11.10.2 Nanospectra Business Overview
11.10.3 Nanospectra Nano Chemotherapy Introduction
11.10.4 Nanospectra Revenue in Nano Chemotherapy Business (2016-2021)
11.10.5 Nanospectra Recent Development
11.11 Merrimack
11.11.1 Merrimack Company Details
11.11.2 Merrimack Business Overview
11.11.3 Merrimack Nano Chemotherapy Introduction
11.11.4 Merrimack Revenue in Nano Chemotherapy Business (2016-2021)
11.11.5 Merrimack Recent Development
11.12 Tarveda
11.12.1 Tarveda Company Details
11.12.2 Tarveda Business Overview
11.12.3 Tarveda Nano Chemotherapy Introduction
11.12.4 Tarveda Revenue in Nano Chemotherapy Business (2016-2021)
11.12.5 Tarveda Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Nano Chemotherapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Medicine Therapy
Table 3. Key Players of Physical Therapy
Table 4. Key Players of Other
Table 5. Global Nano Chemotherapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Nano Chemotherapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Nano Chemotherapy Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Nano Chemotherapy Market Share by Regions (2016-2021)
Table 9. Global Nano Chemotherapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Nano Chemotherapy Market Share by Regions (2022-2027)
Table 11. Nano Chemotherapy Market Trends
Table 12. Nano Chemotherapy Market Drivers
Table 13. Nano Chemotherapy Market Challenges
Table 14. Nano Chemotherapy Market Restraints
Table 15. Global Nano Chemotherapy Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Nano Chemotherapy Market Share by Players (2016-2021)
Table 17. Global Top Nano Chemotherapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nano Chemotherapy as of 2020)
Table 18. Ranking of Global Top Nano Chemotherapy Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Nano Chemotherapy Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Nano Chemotherapy Product Solution and Service
Table 22. Date of Enter into Nano Chemotherapy Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Nano Chemotherapy Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Nano Chemotherapy Revenue Market Share by Type (2016-2021)
Table 26. Global Nano Chemotherapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Nano Chemotherapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Nano Chemotherapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Nano Chemotherapy Revenue Market Share by Application (2016-2021)
Table 30. Global Nano Chemotherapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Nano Chemotherapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Nano Chemotherapy Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Nano Chemotherapy Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Nano Chemotherapy Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Nano Chemotherapy Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Nano Chemotherapy Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Nano Chemotherapy Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Nano Chemotherapy Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Nano Chemotherapy Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Nano Chemotherapy Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Nano Chemotherapy Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Nano Chemotherapy Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Nano Chemotherapy Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Nano Chemotherapy Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Nano Chemotherapy Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Nano Chemotherapy Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Nano Chemotherapy Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Nano Chemotherapy Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Nano Chemotherapy Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Nano Chemotherapy Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Nano Chemotherapy Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Nano Chemotherapy Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Nano Chemotherapy Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Nano Chemotherapy Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Nano Chemotherapy Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Nano Chemotherapy Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Nano Chemotherapy Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Nano Chemotherapy Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Nano Chemotherapy Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Nano Chemotherapy Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Nano Chemotherapy Market Size by Country (2022-2027) & (US$ Million)
Table 62. Amgen Company Details
Table 63. Amgen Business Overview
Table 64. Amgen Nano Chemotherapy Product
Table 65. Amgen Revenue in Nano Chemotherapy Business (2016-2021) & (US$ Million)
Table 66. Amgen Recent Development
Table 67. Celgene Company Details
Table 68. Celgene Business Overview
Table 69. Celgene Nano Chemotherapy Product
Table 70. Celgene Revenue in Nano Chemotherapy Business (2016-2021) & (US$ Million)
Table 71. Celgene Recent Development
Table 72. MagForce AG Company Details
Table 73. MagForce AG Business Overview
Table 74. MagForce AG Nano Chemotherapy Product
Table 75. MagForce AG Revenue in Nano Chemotherapy Business (2016-2021) & (US$ Million)
Table 76. MagForce AG Recent Development
Table 77. Nanotherapeutics Company Details
Table 78. Nanotherapeutics Business Overview
Table 79. Nanotherapeutics Nano Chemotherapy Product
Table 80. Nanotherapeutics Revenue in Nano Chemotherapy Business (2016-2021) & (US$ Million)
Table 81. Nanotherapeutics Recent Development
Table 82. Spectrum Pharmaceuticals Company Details
Table 83. Spectrum Pharmaceuticals Business Overview
Table 84. Spectrum Pharmaceuticals Nano Chemotherapy Product
Table 85. Spectrum Pharmaceuticals Revenue in Nano Chemotherapy Business (2016-2021) & (US$ Million)
Table 86. Spectrum Pharmaceuticals Recent Development
Table 87. Ablynx Company Details
Table 88. Ablynx Business Overview
Table 89. Ablynx Nano Chemotherapy Product
Table 90. Ablynx Revenue in Nano Chemotherapy Business (2016-2021) & (US$ Million)
Table 91. Ablynx Recent Development
Table 92. AMAG Company Details
Table 93. AMAG Business Overview
Table 94. AMAG Nano Chemotherapy Product
Table 95. AMAG Revenue in Nano Chemotherapy Business (2016-2021) & (US$ Million)
Table 96. AMAG Recent Development
Table 97. CytImmune Company Details
Table 98. CytImmune Business Overview
Table 99. CytImmune Revenue in Nano Chemotherapy Business (2016-2021) & (US$ Million)
Table 100. CytImmune Recent Development
Table 101. Delpor Company Details
Table 102. Delpor Business Overview
Table 103. Delpor Nano Chemotherapy Product
Table 104. Delpor Revenue in Nano Chemotherapy Business (2016-2021) & (US$ Million)
Table 105. Delpor Recent Development
Table 106. Nanospectra Company Details
Table 107. Nanospectra Business Overview
Table 108. Nanospectra Nano Chemotherapy Product
Table 109. Nanospectra Revenue in Nano Chemotherapy Business (2016-2021) & (US$ Million)
Table 110. Nanospectra Recent Development
Table 111. Merrimack Company Details
Table 112. Merrimack Business Overview
Table 113. Merrimack Nano Chemotherapy Product
Table 114. Merrimack Revenue in Nano Chemotherapy Business (2016-2021) & (US$ Million)
Table 115. Merrimack Recent Development
Table 116. Tarveda Company Details
Table 117. Tarveda Business Overview
Table 118. Tarveda Nano Chemotherapy Product
Table 119. Tarveda Revenue in Nano Chemotherapy Business (2016-2021) & (US$ Million)
Table 120. Tarveda Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nano Chemotherapy Market Share by Type: 2020 VS 2027
Figure 2. Medicine Therapy Features
Figure 3. Physical Therapy Features
Figure 4. Other Features
Figure 5. Global Nano Chemotherapy Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Other Case Studies
Figure 9. Nano Chemotherapy Report Years Considered
Figure 10. Global Nano Chemotherapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Nano Chemotherapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Nano Chemotherapy Market Share by Regions: 2020 VS 2027
Figure 13. Global Nano Chemotherapy Market Share by Regions (2022-2027)
Figure 14. Global Nano Chemotherapy Market Share by Players in 2020
Figure 15. Global Top Nano Chemotherapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nano Chemotherapy as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Nano Chemotherapy Revenue in 2020
Figure 17. Global Nano Chemotherapy Revenue Market Share by Type (2016-2021)
Figure 18. Global Nano Chemotherapy Revenue Market Share by Type (2022-2027)
Figure 19. North America Nano Chemotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Nano Chemotherapy Market Share by Type (2016-2027)
Figure 21. North America Nano Chemotherapy Market Share by Application (2016-2027)
Figure 22. North America Nano Chemotherapy Market Share by Country (2016-2027)
Figure 23. United States Nano Chemotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Nano Chemotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Nano Chemotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Nano Chemotherapy Market Share by Type (2016-2027)
Figure 27. Europe Nano Chemotherapy Market Share by Application (2016-2027)
Figure 28. Europe Nano Chemotherapy Market Share by Country (2016-2027)
Figure 29. Germany Nano Chemotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Nano Chemotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Nano Chemotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Nano Chemotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Nano Chemotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Nano Chemotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Nano Chemotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Nano Chemotherapy Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Nano Chemotherapy Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Nano Chemotherapy Market Share by Region (2016-2027)
Figure 39. China Nano Chemotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Nano Chemotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Nano Chemotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Nano Chemotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Nano Chemotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Nano Chemotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Nano Chemotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Nano Chemotherapy Market Share by Type (2016-2027)
Figure 47. Latin America Nano Chemotherapy Market Share by Application (2016-2027)
Figure 48. Latin America Nano Chemotherapy Market Share by Country (2016-2027)
Figure 49. Mexico Nano Chemotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Nano Chemotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Nano Chemotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Nano Chemotherapy Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Nano Chemotherapy Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Nano Chemotherapy Market Share by Country (2016-2027)
Figure 55. Turkey Nano Chemotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Nano Chemotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Nano Chemotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Amgen Revenue Growth Rate in Nano Chemotherapy Business (2016-2021)
Figure 59. Celgene Revenue Growth Rate in Nano Chemotherapy Business (2016-2021)
Figure 60. MagForce AG Revenue Growth Rate in Nano Chemotherapy Business (2016-2021)
Figure 61. Nanotherapeutics Revenue Growth Rate in Nano Chemotherapy Business (2016-2021)
Figure 62. Spectrum Pharmaceuticals Revenue Growth Rate in Nano Chemotherapy Business (2016-2021)
Figure 63. Ablynx Revenue Growth Rate in Nano Chemotherapy Business (2016-2021)
Figure 64. AMAG Revenue Growth Rate in Nano Chemotherapy Business (2016-2021)
Figure 65. CytImmune Revenue Growth Rate in Nano Chemotherapy Business (2016-2021)
Figure 66. Delpor Revenue Growth Rate in Nano Chemotherapy Business (2016-2021)
Figure 67. Nanospectra Revenue Growth Rate in Nano Chemotherapy Business (2016-2021)
Figure 68. Merrimack Revenue Growth Rate in Nano Chemotherapy Business (2016-2021)
Figure 69. Tarveda Revenue Growth Rate in Nano Chemotherapy Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
世界のナノセラピー市場規模・現状・予測（2021年-2027年） Nanotherapy is a branch of nanomedicine that involves using nanoparticles to deliver a drug to a given target location in the body so as to treat the disease through a process known as targeting. Much of the research in nanotherapy has been largely directed towards cancer therapy. One of the biggest…- 世界の医療機器用ナノヘルスケア技術市場規模・現状・予測（2021年-2027年） Nano healthcare technology can improve the disease diagnosis by carrying out its incorporation in monitoring devices, bioassay as well as imaging. The active implantable devices segment by product type is anticipated to carry on with its dominating streak during the 2018-2025 assessment period. Mark…
- 世界の化学療法誘発性貧血市場規模・現状・予測（2021年-2027年） Anaemia is a frequent complication of malignancy and is aggravated by chemotherapy. The key factor contributing to the growth of the global chemotherapy induced anemia market is the increase in the occurrence of cancer and anemia among geriatric patients. Market Analysis and Insights: Global Chemoth…
- 世界の化学療法誘発性血小板減少症治療市場規模・現状・予測（2021年-2027年） Cancer is a major chronic disease, which can be managed and treated by chemotherapy, radiation therapy, immunotherapy, hormone therapy, stem cell transplant, targeted therapy, and other therapies. Cancer can be treated by using one therapy or by using combination of therapies based on the stage, typ…
- 世界のナノジルコニアセラミック市場 2021：企業別、地域別、種類・用途別 The Nano Zirconia Ceramic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…